![]() AsclepiX Therapeutics AsclepiX Therapeutics is a biopharmaceutical company which focuses on therapies based on a peptide platform. | ![]() Nkarta Therapeutics Nkarta Therapeutics is a biopharmaceutical company developing engineered natural killer (NK) cell therapies for the treatment of cancer. | ||
Founding Date | Founding Date 2012 | Founding Date 2011 | Founding Date 2015 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations HQ | Locations Baltimore, US HQ Jersey City, US | Locations South San Francisco, US HQ |
Employees | Employees 7 | Employees 7 | Employees 1594% decrease |
Valuation ($) | Valuation ($) 122.2 m | Valuation ($) N/A | Valuation ($) 240.6 m |
Financial | |||
Net income | Net income ($25.5m) (FY, 2024) | Net income N/A | Net income ($108.8m) (FY, 2024) |
Funding | |||
Total funding raised | Total funding raised $ 7.5m | Total funding raised $ 40m | Total funding raised $ 125m |
AsclepiX Therapeutics is a biopharmaceutical company which focuses on therapies based on a peptide platform.
View companyNkarta Therapeutics is a biopharmaceutical company developing engineered natural killer (NK) cell therapies for the treatment of cancer.
View company